SCHEMBL2267889

SCHEMBL2267889

CCCC[SiH2]N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL27279669 0.97
SCHEMBL28262713 0.91
SCHEMBL28263837 0.88 TSHR (0.44)
SCHEMBL28262714 0.88 TSHR (0.44)
SCHEMBL28263840 0.88 TSHR (0.44)
SCHEMBL5486727 0.88 TSHR (0.44)
SCHEMBL28262715 0.88 TSHR (0.44)
SCHEMBL28262709 0.88 TSHR (0.44)
SCHEMBL28263829 0.88 TSHR (0.44)
SCHEMBL28262710 0.88 TSHR (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109075021-A Improved self-assembled monolayer barrier with intermittent air-water exposure 应用材料公司 2018-12-21 CN claimed
CN-110419093-A Treatment method for improving film roughness by improving nucleation/adhesion of silicon oxide APPLIED MATERIALS INC 2019-11-05 CN disclosed
CN-109075021-A Improved self-assembled monolayer barrier with intermittent air-water exposure 应用材料公司 2018-12-21 CN disclosed
CN-101990536-B Pyrollidine-based compounds SHANGHAI TARGETDRUG CO LTD 2014-09-03 CN disclosed
CN-101466725-B Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders SIGMA TAU IND FARMACEUTI 2014-06-25 CN disclosed
US-8404584-B2 Method of manufacturing semiconductor device FUJITSU LIMITED (JP) 2013-03-26 US disclosed
US-20110207319-A1 METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE FUJITSU LIMITED (JP) 2011-08-25 US disclosed
CN-101990536-A Pyrollidine-based compounds SHANGHAI TARGETDRUG CO LTD 2011-03-23 CN disclosed
CN-101466725-A Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders SIGMA TAU IND FARMACEUTI (IT) 2009-06-24 CN disclosed
EP-1925024-A1 CAPPING LAYER FORMATION ONTO A DUAL DAMESCENE INTERCONNECT Freescale Semiconductor, Inc. (US) 2008-05-28 EP disclosed
CN-1253561-A Pyrazolopyrimidinones inhibiting type 5 cyclic guanosine 3',5' -monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction PFIZER LTD (US) 2000-05-17 CN disclosed
CN-1211991-A Compounds with growth hormone releasing properties NOVO NORDISK AS (DK) 1999-03-24 CN disclosed
CN-1197458-A Pyrrolidine derivatives having phospholipase A2 inhibitor activity SHIONOGI & CO (JP) 1998-10-28 CN disclosed
CN-1169722-A 5-lipoxygenase inhibitors PFIZER (US) 1998-01-07 CN disclosed
CN-1030604-C Heterocyclic compounds GLAXO SPA (IT) 1996-01-03 CN disclosed
US-5447799-A Vapor deposition polymerization of second polymer over first deposited on substrate by glow dischage polymerization; dielectric coatings, moisture barriers ADVANCED SURFACE TECHNOLOGY, INC. (US) 1995-09-05 US disclosed
US-5355832-A Forming polymeric material from vaporizable monomers on surface of substrate at low pressure ADVANCED SURFACE TECHNOLOGY, INC. (US) 1994-10-18 US disclosed
CN-1064682-A The preparation method of heterogeneous ring compound GLAXO SPA (IT) 1992-09-23 CN disclosed
CN-1010586-B Process for preparing oxetan-2-ones HOFFMANN LA ROCHE (CH) 1990-11-28 CN disclosed
CN-85109209-A The preparation method of oxa-ring fourth-2-ketone compounds 1986-09-17 CN disclosed